Caries Research
Basic Science
A Proposed Mechanism for the Effects of Saccharin on Glucose Metabolism by Streptococcus mutansBrown A.T. · Best G.M.Department of Oral Biology, College of Dentistry, University of Kentucky, Lexington, Ky., USA
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: November 18, 2009
Issue release date: 1986
Number of Print Pages: 13
Number of Figures: 0
Number of Tables: 0
ISSN: 0008-6568 (Print)
eISSN: 1421-976X (Online)
For additional information: https://www.karger.com/CRE
Abstract
Saccharin inhibited the rate of growth, the amount of acid produced, and glucose utilization by Streptococcus mutans NCTC 10449. One possible mechanism by which saccharin mediates its negative effects upon glucose catabolism is by inhibiting lactate dehydrogenase, the enzyme which catalyzes the terminal, regulatory step in the Embden-Meyerhof-Parnas pathway. The inhibition of lactate dehydrogenase activity by saccharin is dependent upon the fact that it competitively inhibits the binding of its reduced coenzyme, NADH, to the enzyme. The Ki value for saccharin estimated from Dixon plot analysis is 6.2 mM and the inhibitor increased the Km value of NADH from 0.033 to 0.250 mM. In contrast, saccharin had no effect upon the interaction of either its allosteric effector, fructose-1,6-diphosphate, or its substrate pyruvate, with the enzyme. Lactate dehydrogenases assayed in cell-free extracts obtained from members of other S. mutans serotype groups and other oral streptococcal species were also inhibited by saccharin. Saccharin also served to inhibit NAD(H)- and NADP(H)-dependent oxidoreductases in addition to lactate dehydrogenase when assayed in cell-free extracts from S. mutans NCTC 10449 and Streptococcus faecalis. Thus, the saccharin-mediated inhibition of pyridine nucleotide-dependent oxidoreductases may be one manner by which it effects glucose metabolism by this organism.
© 1986 S. Karger AG, Basel
Related Articles:
Article / Publication Details
Published online: November 18, 2009
Issue release date: 1986
Number of Print Pages: 13
Number of Figures: 0
Number of Tables: 0
ISSN: 0008-6568 (Print)
eISSN: 1421-976X (Online)
For additional information: https://www.karger.com/CRE
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission